What is the appropriate IV lidocaine (Loxicard) 2% dosing for a dialysis patient with recurrent ventricular tachycardia?

IV Lidocaine 2% Dosing for Dialysis Patient with Recurrent Ventricular Tachycardia

For a dialysis patient with recurrent VT, administer IV lidocaine 2% at an initial bolus of 1-1.5 mg/kg over 1 minute, followed by a maintenance infusion of 1 mg/min (not the standard 2-4 mg/min), with no dose adjustment needed for the dialysis itself.

Initial Bolus Dosing

The 2010 AHA ACLS guidelines specify an initial dose range of 1 to 1.5 mg/kg IV for hemodynamically stable monomorphic VT 1. This can be repeated at 0.5 to 0.75 mg/kg IV every 5 to 10 minutes up to a maximum cumulative dose of 3 mg/kg if VT persists 1.

Critical calculation point: Use ideal body weight, not actual body weight, particularly important in dialysis patients who may have fluid overload 2. Calculate as: (height in cm - 100) for men; (height in cm - 105) for women.

Maintenance Infusion - Critical Adjustment for Dialysis

Here's where dialysis status fundamentally changes management:

Standard patients: 1-4 mg/min (30-50 mcg/kg per minute) 1

Your dialysis patient: Start at 1 mg/min maximum 3

Recent 2025 data specifically examining heart failure patients (who have similar clearance issues as dialysis patients) demonstrated that 1 mg/min achieved the highest probability (78.6%) of therapeutic lidocaine levels, compared to higher rates which caused supratherapeutic levels 3. While this study focused on heart failure, the principle applies to dialysis patients who also have impaired clearance.

Why Dialysis Doesn't Require Dose Adjustment

Hemodialysis removes negligible amounts of lidocaine - only 5.6% and 2.8% of total dose in studied patients 4. The hemodialysis clearance was approximately 26-29 ml/min for total lidocaine, which is clinically insignificant compared to hepatic metabolism 4. No supplementation is needed after dialysis 4.

Monitoring Requirements

• Continuous ECG and pulse oximetry during initial infusion 2
• Blood pressure every 5 minutes during loading dose and first 15 minutes of maintenance 2
• Watch for CNS toxicity: slurred speech, altered consciousness, drowsiness, perioral numbness, confusion, muscle twitching, seizures 1, 5
• Watch for cardiovascular effects: bradycardia, sinus arrest, hypotension 5

Therapeutic Drug Monitoring

Target therapeutic range: 1.5-5.0 μg/L 3

Measure serum levels if:

• Prolonged infusion (>24 hours)
• High infusion rates
• Change in neurologic status 5
• After 24-48 hours (half-life increases, requiring dose reduction by 1 mg/min) 5

Position in Treatment Algorithm

Lidocaine is now considered a second-line agent for VT. The 2006 ACC/AHA/ESC guidelines give it only Class IIb recommendation (may be reasonable) specifically for VT associated with acute myocardial ischemia or infarction 6. The 2015 ESC guidelines similarly position it as a consideration when amiodarone or beta-blockers fail 7.

First-line options to consider before lidocaine:

• Amiodarone (150 mg over 10 minutes) - Class IIa recommendation 1, 6
• Procainamide (20-50 mg/min) - Class IIa for stable monomorphic VT 6
• Beta-blockers - particularly if ischemia suspected 6

Critical Contraindications and Cautions

Avoid or use extreme caution in:

• Patients >70 years (increased toxicity risk) 5
• Congestive heart failure (half-life >20 hours) 5
• Hepatic dysfunction (lidocaine is almost exclusively hepatically metabolized) 5
• Pre-existing neurologic dysfunction 5

Common Pitfalls

1. Using actual body weight instead of ideal body weight - leads to overdosing
2. Starting maintenance at 2-4 mg/min in dialysis patients - the standard dose is too high for impaired clearance states
3. Assuming dialysis removes significant lidocaine - it doesn't, so don't supplement post-dialysis 4
4. Continuing high infusion rates beyond 24 hours - reduce by 1 mg/min at 12-24 hours 5
5. Using lidocaine as first-line - amiodarone and procainamide are preferred unless acute ischemia is present 6, 7

Practical Administration

• Use dedicated IV line with minimum 10 ml/h saline flush 2
• Administer through lockable infusion pump 2
• Do not mix with other local anesthetic interventions within 4 hours 2
• If VT recurs after 8-10 hours at steady infusion, give additional 0.5 mg/kg bolus AND increase maintenance rate 5